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Abstract (up to 300 words)  
Objective 
Detection of Barrett’s esophagus (BE) at points of care outside the endoscopy suite may 
improve screening access and reduce esophageal adenocarcinoma mortality. Tethered 
capsule optical coherence tomography (OCT) can volumetrically image esophageal 
mucosa and detect BE in unsedated patients. We investigated ultrahigh-speed tethered 
capsule, swept-source OCT (SS-OCT) in unsedated patients, improved device design, 
developed procedural techniques, measured how capsule contact and longitudinal 
pullback non-uniformity affect coverage, and assessed patient toleration.  
Design 
OCT was performed in 16 patients prior to endoscopic surveillance/treatment. Unsedated 
patients swallowed the capsule with small sips of water and the esophagus imaged by 
retracting the tether. Ultrahigh-speed SS-OCT at 1,000,000 A-scans/second imaged 
~40cm2 esophageal areas in 10 seconds with 30µm transverse and 8µm axial resolution. 
Capsule contact and longitudinal image coverage were analyzed. Patients were 
interviewed to assess toleration.  
Results  
Nine patients had non-dysplastic BE, 3 had ablative treatment-naïve neoplasia, and 4 
had prior ablation for history of dysplasia. Dry swallows facilitated capsule transit through 
the lower esophageal sphincter (LES), and waiting 10 seconds before retrieval reduced 
swallow-induced LES relaxation. Slow nasal inhalation facilitated capsule retrieval and 
minimized the gag reflex. The capsule procedure was well tolerated. Ultrahigh-speed SS-
OCT enabled the generation of cross-sectional and sub-surface en face images. BE could 
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be rapidly identified in cross-sectional and en face images, while assessment of the 
gastro-esophageal junction (GEJ) required subsurface en face views. Capsule-
esophageal contact was worse in long-segment BE and sliding hiatal hernia, and 
longitudinal image coverage was worse in short-segment BE. OCT candidate features of 
dysplasia are reported.  
Conclusions  
Ultrahigh-speed tethered capsule SS-OCT enabled en face and cross-sectional imaging 
of mucosal features over wide areas. Device and procedure optimization led to improved 
imaging performance. Areas of BE could be readily identified, but limited capsule contact 
and longitudinal image coverage can yield sampling errors.  
 
Summary Box (separate from abstract) 
What is already known about this subject? 
Modalities for Barrett’s esophagus screening and risk stratification outside the endoscopy 
suite can improve access to care and potentially reduce mortality. Previous optical 
coherence tomography (OCT) imaging studies with balloons and tethered capsules have 
shown diagnostic potential for BE and dysplasia, but acquire sparse cross-sectional 
images with limited resolution and coverage. Procedural information on tethered capsule 
OCT has been limited.  
 
What are the new findings? 
Ultrahigh-speed SS-OCT tethered capsules can generate en face and cross-sectional 
images, mapping wide areas of the esophagus and gastroesophageal junction, enabling 
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quantitative assessment of surface and subsurface features in patients without requiring 
endoscopy or sedation. Device design and procedural techniques are described for 
optimizing examination performance in unsedated patients.  
 
How might it impact on clinical practice in the foreseeable future? 
Next-generation, ultrahigh-speed SS-OCT tethered capsule imaging may improve 
screening for Barrett’s esophagus and risk stratification at points of care outside the 
endoscopy suite.  
  
7 
 
Introduction 
Barrett’s esophagus (BE) and dysplasia are precursors to esophageal 
adenocarcinoma (EAC). However, 90% of EAC patients never receive an endoscopic BE 
diagnosis[1] and 40% do not report symptoms of chronic gastroesophageal reflux 
disease[2]. Therefore new BE screening methods that can be used at points of care 
outside the endoscopy suite are needed to improve early detection of BE before 
progression to EAC. The Cytosponge has been validated for BE detection in large trials 
with 80% sensitivity and 92% specificity[3], and evaluated for risk stratification[4]. 
Unsedated transnasal endoscopy has been compared to endoscopy, showing 
comparable detection of BE, although transnasal intubation requires expertise and 
tolerability results have been mixed[5 , 6]. Breath testing has demonstrated ~80% 
sensitivity/specificity to BE[7]. DNA methylation markers and a swallowable device for 
tissue sampling achieved >90% sensitivity/specificity to BE[8].  
Endoscopic optical coherence tomography (OCT) can image subsurface tissue 
architectural morphology and early studies suggested its potential for BE and dysplasia 
detection[9]. Balloon-based OCT has been commercialized as volumetric laser 
endomicroscopy (VLE, NinePoint Medical)[10]. Tethered capsules can be swallowed 
without sedation; early string-tethered video capsules showed sensitivity and specificity 
of 93.5% and 78.7% compared with histological BE diagnosis[14], and were later adapted 
for OCT imaging[15]. OCT tethered capsules can image long lengths of the esophagus 
by slow retraction of the tether after swallowing. OCT capsule studies demonstrated 
cross-sectional images, reported excellent patient toleration[16] and showed correlations 
with endoscopic Prague measurements[17]. However, there are limited investigations of 
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capsule contact with the esophagus and non-uniform longitudinal capsule motion, which 
reduce image coverage and cause sampling errors. Procedural details for tethered OCT 
capsule imaging in unsedated patients have also been limited.  
Our group previously reported ultrahigh-speed OCT using micromotor probes 
introduced into the endoscope working channel that generate en face and cross-sectional 
views enabling 3-dimensional assessment of tissue architectural morphology[18]. Using 
micromotor imaging probes, we reported en face and cross-sectional OCT features 
associated with BE and dysplasia[19]. We also evaluated the feasibility of ultrahigh-speed, 
micromotor tethered capsule OCT for volumetric and en face imaging >20cm lengths of 
the esophagus in sedated patients during endoscopy, demonstrating large field-of-view, 
detecting BE, and suggesting features associated with dysplasia[20]. Here we report 
ultrahigh-speed, tethered capsule OCT for mapping the esophagus and imaging BE in 
unsedated patients. We describe device improvements, procedural techniques for 
optimal imaging, measure capsule contact, and longitudinal image coverage for BE 
detection, and assess patient toleration. This information is relevant for future study 
design and wider-spread screening applications.  
 
Methods 
Imaging system and tethered capsule 
Tethered capsule OCT imaging was performed using a prototype ultrahigh-speed 
swept-source OCT (SS-OCT) instrument operating at 1,000,000 A-scans/second, 20x 
faster than commercial endoscopic OCT (VLE NinePoint). The tethered capsules (Figure 
1A-B) used micromotors for circumferential imaging at 300 cross-sectional images per 
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second[20] with 30µm transverse and 8µm axial resolution. Several improvements were 
made over previously reported capsule designs[16]. Our new capsule was 12mm 
diameter with proximal and distal ends made with lubricious, medical-grade ultrahigh-
molecular-weight polyethylene and a small polycarbonate transparent window for the 
OCT beam. This new design reduced friction, allowing the capsule to be swallowed and 
retrieved smoothly. The proximal end had a 30 taper, improving pullback smoothness 
and ease of retrieval through the lower esophageal sphincter (LES) and upper 
esophageal sphincter (UES). The tether was 2.2mm diameter, providing flexibility for 
patient comfort while retaining some rigidity for operator control, and was marked at 5cm 
intervals to assess capsule distance from the incisors.  
 
Patient recruitment and imaging procedure 
The study was approved by IRBs at the Veterans Affairs Boston Healthcare System, 
Harvard Medical School, and Massachusetts Institute of Technology. Written informed 
consent was obtained from patients undergoing BE surveillance or endoscopic treatment 
for prior diagnosed neoplasia. Neoplasia was defined to include low-grade dysplasia 
(LGD), high-grade dysplasia (HGD), and intramucosal carcinoma (IMC). Patients were 
scheduled for same-day sedated endoscopy and underwent standard endoscopy 
preparation.  
Prior to sedation and endoscopy, patients swallowed the tethered capsule with small 
sips of water while sitting upright. The procedure was supervised by an endoscopist who 
controlled the tether. Wet and dry swallows facilitated capsule transit into the stomach, 
and the capsule was positioned at the gastric cardia, as monitored using real-time OCT 
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imaging. The endoscopist then imaged a ~10cm long segment of the esophagus by 
pulling back the tether at ~1cm/sec for ~10sec, causing the capsule to move longitudinally 
through the GEJ (Figure 1C). The pullback length was estimated by the tether markings. 
Dense volumetric datasets with ~10 million A-scans and ~5 gigavoxels, covering a 
~40cm2 area of the esophagus were acquired (Figure 1D).  
Patients were asked to take dry swallows to improve capsule contact with the 
esophageal wall, and the endoscopist waited ~10 sec prior to the pullback in order to 
avoid swallow-induced LES relaxation (deglutitive inhibition)[21]. Imaging was performed 
during pullback and not during the capsule’s natural migration after swallows because 
peristalsis, generally progressing at several cm/sec, is too rapid for dense volumetric 
imaging. Capsule contact with the esophagus was assessed by observing the cross-
sectional image series and en face images. If substantial out of contact regions were 
noted, additional dry/wet swallows were performed to improve contact before repeating 
pullback image acquisitions. If excessive longitudinal capsule motion non-uniformity 
occurred, as indicated by longitudinal stretching or compression of features in the en face 
image, additional pullback acquisitions were repeated after a brief 10-15 sec wait post-
swallow to avoid the rebound LES contractions. After imaging, the capsule was retrieved 
by retracting the tether. Swallowing motions were not effective for capsule retrieval 
because the relaxation of the UES is transient and this places the posterior tongue closer 
to the tether, causing gagging. Instead, patients were asked to perform slow nasal 
inhalation, minimizing gag reflex from the posterior tongue.  
Patients then underwent sedated endoscopy ~2-4 hours later, following the American 
Society for Gastrointestinal Endoscopy guidelines requiring 2-hour fasting after ingestion 
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of clear liquids before intravenous sedation[22]. During endoscopy, measurements were 
obtained of BE length and diaphragmatic hiatus. Seattle protocol 4-quadrant biopsy was 
performed in non-dysplastic BE (NDBE) surveillance patients, and endoscopic treatment 
performed in patients with prior diagnosed dysplasia, per standard of care. In patients 
referred for treatment with known prior treatment-naïve dysplasia, biopsies/resections 
were not systematically obtained unless clinically indicated. 
After tethered capsule OCT and endoscopy, a research nurse performed a brief 
patient interview to assess toleration for unsedated tethered capsule OCT and sedation 
endoscopy. The post-procedure patient interview questions were: “How anxious did you 
feel before the procedure? 1 not, 5 very”, “How much discomfort did you have during the 
procedure? 1 none, 5 a lot”, and “Would you recommend the procedure to others? 1 
definitely yes, 5 definitely no”. The questions were identical to those reported in previous 
OCT capsule imaging studies in order to facilitate comparison[16]. 
 
Data analysis  
Datasets were assessed for image quality and one optimal dataset from each patient 
was selected for analysis. The region of analysis on the en face OCT images was defined 
to be the portion of the esophageal wall that closely encircled the capsule, with proximal 
margin at the squamocolumnar junction (SCJ) maximal extent and longitudinal extent as 
observed by endoscopy (Prague M length). The endoscopically observed BE length was 
used to help delineate the extent of BE in the en face OCT images because the GEJ is a 
morphological transition zone that could not be reliably delineated by OCT features alone. 
Since this analysis was retrospective, endoscopic measurements aided the OCT 
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assessment. However, this suggests that quantitative measurements of BE length 
(Prague M length) using OCT alone will be challenging because of uncertainty in GEJ 
location. Analogously, endoscopic identification of the GEJ relies on discerning the top of 
the gastric folds, a gross anatomical landmark that is similarly prone to uncertainty.  
The longitudinal capsule motion was non-uniform compared with the tether pullback, 
therefore regions, where the capsule moved more slowly/rapidly, could be detected as 
stretching/compression of features in the longitudinal direction of the en face OCT images. 
This pullback non-uniformity caused distortion or gaps in the OCT data, limiting 
longitudinal image coverage, producing sampling errors. This also made quantitative 
measurements of BE length (Prague M length) challenging.  
Contact of the capsule with the esophagus and longitudinal motion non-uniformity 
were analyzed as metrics for image coverage and sampling error. Capsule-tissue contact 
was measured as the percent of the capsule circumference where the esophagus was 
within ~100µm from the capsule surface. The mean of the capsule-tissue contact was 
calculated from the region in the en face OCT from the GEJ to the maximal extent of 
visible BE at the SCJ. Squamous mucosa regions proximal to the SCJ maximal extent 
were excluded from the analysis, because these areas usually showed good contact, but 
were less relevant to BE assessment.  
Longitudinal image coverage was assessed by identifying longitudinally stretched 
regions in the en face OCT where the capsule stopped or moved too slowly relative to the 
esophagus during pullback. The percentage of the image with longitudinal stretching was 
calculated. However, areas where the capsule moved too fast relative to the esophagus 
appeared as longitudinally compressed regions in en face OCT. These regions comprise 
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a negligible portion of the total longitudinal image but represent the sampling error. The 
image data is displayed as a function of time. The regions with overly slow motion were 
assumed to be approximately equal to the regions with overly fast motion because the 
tether pullback speed is constant and therefore the overall pullback length and time are 
known. Therefore we used the longitudinally stretched areas in the en face OCT as a 
marker for estimation of longitudinal image coverage and sampling error.  
Tissue contact and longitudinal image coverage were stratified by short/long-segment 
BE (<=3cm and >3cm), and absence/presence of sliding hiatal hernia (the distance of 
diaphragmatic hiatus from gastric folds <=2cm and >2cm) subgroups.  
The patient toleration (anxiety and discomfort) and recommendation scores were 
analyzed. The toleration score distributions were stratified by pathology and treatment 
subgroups to show possible associations with prior endoscopy and/or treatment 
experience. Statistical analysis was not performed due to the small enrollment size and 
the observational nature of the study.   
 
Results 
Patient demographics and clinical characteristics 
Sixteen patients were enrolled. Table 1 summarizes patient demographics including 
baseline pathology (neoplasia status) at the time of imaging, treatment history, and BE 
length. A mean of 4827 milliliters of water was consumed during the tethered capsule 
procedure. In all but one patient, tethered capsule imaging was followed by an 
esophagogastroduodenoscopy (EGD). This patient was scheduled for an unrelated 
colonoscopy, but was in ongoing surveillance for long-segment BE, with a recent EGD in 
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the previous year. Therefore, this patient was not asked to provide toleration scores for 
endoscopy. 
 
Tissue contact with capsule and longitudinal coverage 
A mean of 5.51.3 pullback datasets were obtained per patient, from which an optimal 
dataset was selected. In 16 patients, there was a 75±27% mean percent of tissue-capsule 
contact averaged over the en face BE region of analysis. Longitudinal image coverage 
was 59±34% of the BE segment. Tissue contact was associated with endoscopic BE 
length and sliding hiatal hernia (Figure 2). The mean tissue contact was 89±11% for short-
segment BE with/without prior ablative treatment (n=8) patients, and 61±31% for long-
segment BE (n=8) (p=0.03). The mean tissue contact was 84±15% in patients without 
sliding hiatal hernia (n=11), and 5537% with hernia (n=5) (p=0.04). Folds in the 
esophagus sometimes occurred, suggesting that the percent of esophagus which was 
not imaged exceeds the percent of capsule circumference which was out of contact. Also, 
BE is not fully circumferential in patients with Prague M>C. Therefore, the percentage of 
BE imaged may be greater or less than that inferred from capsule contact.  
 
Toleration scores 
 The mean procedure time for tethered capsule imaging was 9.7±3.0 minutes. For 
capsule imaging (n=16), the mean pre-procedure anxiety was 1.9±1.0, procedural 
discomfort was 2.5±1.1, and recommendation score was 1.3±0.7. For endoscopy (n=15), 
the mean pre-procedure anxiety was 1.3±0.7, procedural discomfort was 1.6±0.9, and 
recommendation score was 1.1±0.3. Toleration did not appear to be associated with the 
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number of imaging pullbacks performed. The toleration score distributions, grouped by 
patient history of pathology/treatment are presented in Figure 3.  
 Toleration scores stratified by pathology and treatment history were generally 
consistent between subgroups, suggesting that toleration may be independent of prior 
endoscopy and treatment experience. Endoscopy was better tolerated than the tethered 
capsule, likely due to sedation. Our toleration scores show marginally lower pre-
procedure anxiety (1.91.1 vs 2.10.8) and higher procedural discomfort (2.51.0 vs 
1.90.9) than previous reports[16], possibly due to our larger capsule diameter (12 mm 
vs 11 mm) chosen for better tissue contact. These results suggest that tethered capsule 
OCT is well-tolerated, although both our study and the previous study were single-center 
and our study enrollment was all male veterans, so results are not generalizable. There 
were no adverse events during the entire study. 
 
OCT features of BE 
 Figure 4 shows a wide-field en face OCT over an entire BE segment from GEJ to 
SCJ. This data is from the patient who did not receive same-day EGD but had known 
long-segment NDBE from two EGDs 9 months prior and 4 years prior (4-quadrant 
biopsies found no dysplasia). OCT showed almost complete contact of the esophageal 
mucosa to the capsule, while some loss of longitudinal coverage from longitudinal capsule 
motion non-uniformity was observed.  
Numerous dilated glands were observed over the entire BE segment, and an 
exceptionally high number of gland clusters was observed on the gastric side of the GEJ. 
This example showed exceptionally well-defined boundaries of the gastroesophageal 
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junction (GEJ) and squamocolumnar junction (SCJ). This example also illustrates that 
important OCT markers may frequently occur at the gastric cardia around the GEJ, even 
in low-risk NDBE patients[23]. Features at the GEJ can confound attempts to identify 
neoplasia, particularly if the GEJ boundary is poorly defined and wide-field en face OCT 
views are unavailable. We report candidate OCT features for dysplasia in the 
Supplementary Information.  
 
Discussion 
We report a pilot study using ultrahigh-speed, tethered capsule SS-OCT imaging for 
wide-field, en face and cross-sectional visualization. Previous studies with commercial 
OCT instruments used slower, 50,000 A-scans per second, imaging speeds and lower, 
40µm transverse resolution, generating sparsely-spaced, cross-sectional image volumes 
that did not have high resolution en face views. Our OCT technology at 1,000,000 A-
scans/sec and 30µm resolution can generate densely sampled volumes enabling en face 
imaging over wide fields of view. Previous OCT capsule studies investigating screening 
recruited largely from a primary care population, whose patients had little or no BE, and 
those study designs did not ensure same-day endoscopy for direct comparison. In this 
study, we recruited from a heterogeneous BE surveillance population in which patients 
had various BE lengths and history of dysplasia. Improved capsule design using 
lubricious materials and tapered form factor, improved procedural workflow, and 
increased capsule imaging performance. This study assessed procedures and 
performance for imaging unsedated patients prior to endoscopy, however, tethered 
capsule imaging can also be performed during endoscopy.  
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Limitations of this study include the lack of histological correlation with OCT features. 
4-quadrant biopsies were performed in patients with NDBE history, but patients with prior 
treatment-naïve dysplasia and referred for treatment were not systematically biopsied. 
We performed additional analyses of OCT features that may be associated with dysplasia 
(Supplementary Information), with the caveat that these observations had histological 
corroboration on per-patient basis, but not at the precise location where the OCT features 
were found. Our capsule did not have the capability to mark areas of interest for biopsy 
or to obtain biopsy directly. However, laser marking based on cross-sectional image 
guidance using tethered capsules has been reported[24]. Future capsule studies could 
adapt the laser marking paradigm to guide biopsy based on both en face and cross-
sectional features. Another limitation was the small patient enrollment from a single-
center, therefore results on toleration, image coverage and image quality may not 
generalize to larger studies. However, this type of pilot study is important for optimizing 
device design and examination protocols; identifying candidate OCT markers of BE, 
dysplasia and risk stratification; and designing future large prospective studies.   
Close contact of the capsule with the esophagus is critical for OCT visualization, 
assuring that the circumference of the esophagus is imaged and within the optical focus 
depth-of-field. Reduced esophageal contact can introduce optical aberrations that reduce 
OCT visibility of mucosal microstructure, and esophageal folds can obscure areas from 
view. These effects reduce image coverage and produce sampling errors. Previous 
studies suggested that swallow-initiated peristaltic contractions would ensure contact 
between capsule and esophagus. However, in our experience, patient swallows were 
helpful, but a substantial minority of patients had poor contact despite repeated dry/wet 
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swallows and avoiding deglutitive inhibition of the LES. The short-segment BE patients 
(n=8) showed superior tissue contact compared to long-segment BE patients (n=8) 
(contact 8911% vs 6131%, p=0.03) (Figure 3). Patients without sliding hiatal hernia 
(n=11) showed superior contact compared to those with hernia (n=5) (contact 8415% vs 
5537%, p=0.04). Early studies of esophageal motility in BE found associations between 
long BE lengths and reduction of LES tone and peristaltic amplitude[25]. The reduced 
LES tone associated with sliding hiatal hernia[21] may also contribute to poor contact. In 
the future, contact might be improved using an articulating mechanism to appose the 
capsule to the esophageal wall.   
Longitudinal capsule motion uniformity is necessary for high-quality en face 
visualization. The capsule moved slower/faster than the tether pullback during portions of 
the OCT acquisitions, resulting in a localized stretched/compressed appearance in en 
face images and sampling errors. Previous studies with micromotor imaging probes[18] 
used 2mm/sec motorized pullback of the scanning optics within a transparent sheath to 
acquire volumetric OCT. Our tethered capsule was manually pulled back at ~1cm/sec 
while in contact with the esophagus. In our previous study using a tethered capsule during 
sedated endoscopy[20] capsule motion was non-uniform at slow speeds due to friction. 
The lubricious housing used in the current capsule reduced friction and the faster 1cm/sec 
pullback improved capsule longitudinal motion uniformity.  
During pullback, the operator reported occasional resistance from anatomic variations, 
peristalsis, LES tone and/or rebound contractions, leading to non-uniform pullback. The 
operator did not forcefully pull through these resistances, which are meaningful 
anatomical signals for safe and effective use. Short-segment BE had more non-uniform 
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capsule motion compared with long-segment BE, possibly because the contact produced 
by strong LES tone increased friction. Conversely, long-segment BE had looser tissue-
capsule contact, which may enable smoother capsule motion. Smooth pullback and 
capsule-tissue contact generally showed opposite (inverse) trends, because contact 
produced friction. Non-uniform capsule longitudinal motion produces 
stretching/compression artifacts in the en face image, however, distortion occurs only in 
the pullback direction and image features can still be interpreted by experienced readers. 
Future attempts to perform more precise quantitative measurements or reduce sampling 
error in en face OCT images should incorporate more sophisticated motion artifact 
correction or motion tracking. Further increases in imaging speed will be possible and will 
enable faster pullbacks with reduced friction and improved longitudinal image coverage 
and uniformity, although pullback speeds may need to be moderated while traversing 
constrained sphincters.   
Limitations in capsule contact produce sampling error and suggest that the current 
version of the capsule would not be suitable as an unsedated imaging modality for low-
cost surveillance of focal pathologies such as dysplasia. However, capsules can still be 
used for screening because sampling errors would not appreciably compromise detection 
sensitivity for BE, although other methods for screening are also promising[3 , 5 , 8]. For 
surveillance applications, a capsule imaging device might be used during sedation 
endoscopy. The capsule could be attached to the endoscope (similar to a focal RFA 
catheter) and articulated to contact the esophageal wall, mapping longitudinal extent by 
advancing or retracting the endoscope. This protocol should enable comprehensive 
imaging coverage as well as access to the GEJ, areas of hiatal hernia, and gastric cardia. 
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The ultrahigh-speed tethered capsule produces better images than balloon OCT devices, 
should have better image coverage and could be multi-use, reducing cost.   
Ultrahigh-speed tethered capsule OCT can visualize mucosal architectural 
morphology over wide fields-of-view. This technology may help the early screening of BE 
and risk stratification. Additional larger studies with histological correlation are warranted.  
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Tables and Figures 
 
Age, mean (± SD) 68 (7) 
Sex, male, no. (%)  16 (100) 
Race, white, no. (%) 16 (100) 
Baseline pathology and treatment status 
NDBE subjects, no. (%) 
Short-segment (<=3cm) Barrett’s Esophagus 
(BE), no. (%) 
 
9 (56) 
2 (13) 
LGD subjects, no. (%) 
Ablative treatment-naïve subjects, no. (%) 
Short-segment BE, no. (%) 
Treated subjects, no. (%) 
Residual short-segment BE, no. (%) 
4 (25) 
1 (6) 
1 (6) 
3 (19) 
3* (19) 
HGD/IMC subjects, no. (%) 
Ablative treatment-naïve subjects, no. (%) 
Short-segment BE, no. (%) 
Treated subjects, no. (%) 
Residual short-segment BE, no. (%) 
3 (19) 
2† (13) 
1 (6) 
1 (6) 
1 (6) 
Length of BE at study endoscopy, cm 
Circumferential extent, mean (± SD) 
Maximal extent, mean (± SD) 
Short-segment (<=3cm) subjects, no. (%) 
 
3.6 (4.3) 
5.1 (4.5) 
8 (50) 
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Long-segment (>3cm) subjects, no. (%) 8 (50) 
Distance from diaphragmatic hiatus (D) to gastric folds (G), 
mean (± SD) 
Subjects with sliding hiatal hernia (D-G >2cm), no. (%) 
Length of hiatal hernia, mean (± SD) 
2.3 (2.5) 
 
5 (31) 
5.6 (2.1) 
*One treated LGD patient had no visible BE on endoscopy and was classified as short-
segment BE. 
†One HGD/IMC patient had prior endoscopic mucosal resection and no ablation, thus 
classified as ablative treatment-naive. 
 
Table 1. Patient demographics and clinical characteristics (n=16). 
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Figure 1. A: Photograph of tethered OCT capsule constructed using lubricious material 
with a 30 proximal taper for ease of retrieval. B: Schematic showing micromotor rotary 
optical scanner and other components. C: Cartoon showing capsule traveling from gastric 
cardia into distal esophagus during a pullback scan. D: Illustration showing multiple cross-
sectional images rapidly acquired in rapid succession during capsule pullback to obtain 
volumetric data for subsurface en face and cross-sectional visualization.  
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Figure 2. Boxplots of tissue contact and longitudinal capsule motion uniformity/coverage 
over the en face BE region in the tethered capsule OCT datasets. Colored circles indicate 
individual data points. Tissue contact was significantly different (*) between short/long 
segment BE (p=0.03) and absence/presence of sliding hiatal hernia (p=0.04). 
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Figure 3. Pre-procedure anxiety and procedural discomfort scores for the tethered 
capsule and endoscopy procedures. 1- no anxiety/discomfort, 5- high anxiety/discomfort. 
Scores between patient subgroups of baseline pathology and treatment history were 
similar. 
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Figure 4. Tethered capsule OCT from a patient with C2M4 non-dysplastic BE. (A) en face 
OCT at 200 µm depth, (B) 400 µm depth, and (C) full depth projection. Scale bars 1 cm. 
Some longitudinal capsule motion non-uniformity can be observed in the BE segment. 
(D-F) Enlargements showing glands and mucosal pattern at the GEJ. Scale bars 1 mm. 
(G) Cross-sectional OCT from the GEJ showing atypical glands. Scale bar 500 um. 
Biopsy at the GEJ (inset) from a prior EGD (9 months earlier) shows a large dilated 
cardiac gland (arrow) with smaller peripheral glands from the superficial mucosa. 
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Supplementary Information 
 
OCT features of dysplasia 
Tethered capsule OCT enables wide-field imaging and can potentially identify 
focal regions of dysplasia in non-dysplastic Barrett's esophagus (NDBE). Here, we 
present preliminary findings that suggest candidate markers for dysplasia which could 
be tested in future studies.   
Methods 
The tethered capsule OCT datasets were assessed by an expert reader (KCL) 
for candidate features of dysplasia. The reader was unblinded to patient history and 
endoscopic findings in order to identify distinctive image features/traits associated with 
clinical history and biopsy histology. Two candidate features were identified and 
assessed: atypical gland clusters (AGCs)[1] and irregular mucosal patterns (IMPs)[2]. 
AGCs were defined as atypical glands, including non-elliptical shape, branching or 
internal debris, with a clustered density of >5 atypical glands appearing over the depth 
of BE in a 5mm square (25mm2) en face area, observable in en face images down to 
~1mm deep in BE mucosa. The en face density criteria for atypical glands were added 
to previous cross-sectional criteria[1], in accordance with previous en face OCT 
studies[2]. The 5mm square area criteria was chosen as a threshold based on 
assessment of the image data because glands distributed over a larger area in en face 
images appeared to be unassociated. Adjacent areas that had >5 atypical glands were 
recorded as a single clustered region. The 1mm depth range was chosen to 
encompass the boundary of lamina propria and muscularis mucosa. AGCs were 
assessed using simultaneous ‘orthoplane’ viewing of the en face and cross-sectional 
image series. En face IMPs were defined following recent en face OCT studies[2] and 
using criteria similar to narrowband imaging (NBI)[3], including distortion/absence of 
mucosal patterns. The two features were assessed separately and demarcated in the 
en face images. The features were counted to determine the absolute occurrence rate 
(occurrences/patient), per-area occurrence rate (occurrences/approximate contacted 
area), and occurrence rate of IMP with underlying AGC. Features occurring in BE near 
(within 1cm of the GEJ) were noted.   
Results 
Supplementary Figure 1 shows representative results from a treatment-naïve 
patient referred for treatment for prior histological LGD diagnosis. The area imaged 
(Figure 2A) was ~4cm (capsule circumference) x ~9cm (approximate pullback length). 
The mean tissue contact over the en face BE region of analysis was 98%. The capsule 
moved slower/faster than the tether pullback over some regions, resulting in a 
stretched/compressed appearance because the en face image is displayed versus 
time, rather than the actual longitudinal distance traveled by the capsule. Despite 
these artifacts, features in the en face images are distorted only in the longitudinal 
direction and can be interpreted by experienced readers. AGCs (Figure 1B-C) were 
observed in the en face images. A contrast-enhanced, full depth projection en face 
OCT image (Figure 1D) was used to visualize regions of regular mucosal patterns 
(Figure 2G), IMPs (Figure 1E-F), and absence of pattern (interpreted as irregular) 
(Figure 1H). Some IMPs had underlying AGCs. Cross-sectional images also showed 
atypical glands (Figure 1I-J), as well as features such as surface signal > subsurface 
(Figure 1K), and normal columnar epithelium (Figure 1L). 
Supplementary Table 1 and Figure 2 summarize the features observed in the 
patient cohorts (history of NDBE vs dysplasia/treatment). The occurrence rates of 
IMPs, AGCs, and overlapping (combined) features are reported on a per-patient and 
per-area basis. In the neoplasia cohort, IMPs with underlying AGCs had 1.7 
occurrences/patient and 0.36 occurrences/area, while in the NDBE cohort there were 
only 0.22 occurrences/patient and 0.01 occurrences/area.  
The occurrence rate for the NDBE cohort is reported by patient history at the 
time of imaging, noting that 2/9 patients in the NDBE cohort each had a single 
occurrence of IMP with underlying AGC; standard endoscopic Seattle protocol of 4-
quadrant biopsies obtained from the longitudinal position closest to the observed 
features showed LGD in one patient and indefinite dysplasia in the second patient. 
Thus, the rate of IMP with underlying AGC in the 7 patients with true NDBE status was 
zero occurrences/patient. These results suggest a strong association of IMP and 
underlying AGC with neoplasia, albeit in a small study cohort. 
Discussion 
The occurrence rates of IMPs and AGCs in this study were associated with 
neoplasia status and treatment history. IMPs with underlying AGCs occurred more 
frequently in treatment naïve neoplasia patients (3/3 patients, 3.0 occurrences/patient, 
0.31/area) than in the treated neoplasia cohort (2/4 patients, 0.75 occurrences/patient, 
0.40/area). 2/9 patients in the history of NDBE cohort had no endoscopically visible 
lesions and received only Seattle protocol, but OCT imaging revealed IMPs with 
underlying AGCs. These patients were subsequently found to have LGD and indefinite 
dysplasia on 4-quadrant biopsies from the approximate longitudinal position of these 
OCT features. The remaining 7 patients with NDBE history did not have IMPs with 
underlying AGCs and did not have dysplasia on Seattle protocol biopsy. These 
findings suggest that IMPs with underlying AGCs are a candidate marker for dysplasia 
and elevated risk.  
These results are consistent with a previous endoscopic study using 
micromotor OCT probes with biopsy or endoscopic mucosal resection (EMR) histology 
from the OCT imaged region[2]. Micromotor probes image a small (~10mm x 16mm) 
field-of-view compared to the tethered capsule (~4cm x 10cm). However, spatially 
correlated biopsy/resection can be performed using a dual-channel endoscope. In the 
previous study, blinded reading of 74 OCT datasets with correlated histology (49 
NDBE, 25 neoplasia) from 44 patients identified atypical glands under IMPs in 75% of 
neoplasia (96% of treatment-naïve neoplasia) vs. 30% of NDBE (43% of short- and 
18% of long-segment NDBE)[2].  
Atypical glands can be assessed using either en face or cross-sectional views, 
but the extent and organization of clustering are more readily appreciated in en face 
views. Atypical glands are associated with neoplasia, but also occur in NDBE, 
reducing specificity for this feature[4]. The present study showed AGCs occurred at 
rates of 3.0/patient and 0.60/area in neoplasia, versus 1.3/patient and 0.30/area in 
patients with NDBE history. A multi-center study of NBI criteria for dysplasia based on 
en face features including IMPs showed 80% sensitivity and 88% specificity[3]. Either 
AGCs or IMPs can have substantial independent occurrences, but their combination 
(AGC under IMP) may have a sensitive and more specific association with neoplasia. 
The combination of OCT atypical gland criteria with en face IMPs from either NBI or 
OCT may improve the detection of neoplasia vs NDBE.  
A substantial fraction of features in all cohorts occurred near the GEJ 
(Supplementary Table 1), a region reported to have low OCT feature specificity[2 , 5]. 
Glands in the proximal cardia may be mistaken for atypical glands near the GEJ and 
result in over-counting / false positives[6]. The role of cardiac mucosa at the GEJ is 
debated, and it has been proposed that GEJ glands may progress to BE and have 
pre-malignant potential[7]. The large field-of-view and en face visualization provided 
by tethered capsules may improve GEJ assessment compared to slower cross-
sectional OCT balloon imaging and elucidate the pathogenesis of BE and dysplasia 
originating from GEJ features. Treated patients appeared to have higher rates of IMPs 
and AGCs. This finding might be associated with the ablation procedure, however, 
these patients had short residual BE lengths after prior treatment; therefore the 
majority of features were near the GEJ, where glands in the proximal cardia might be 
mistaken for AGCs.  
Limitations of this analysis include the lack of histological correlation with OCT 
features. 4-quadrant biopsies were performed in patients with NDBE history, but 
patients with prior treatment-naïve dysplasia referred for treatment were not 
systematically biopsied. Two patients in the NDBE history cohort each had a single 
occurrence of IMP with underlying AGC, with biopsy showing dysplasia and indefinite 
for dysplasia respectively. Furthermore, our results are consistent with a recent study 
using micromotor OCT probes which had correlated biopsy/EMR histology[2]. Our 
tethered-capsule did not have the capability to mark regions for biopsy or directly 
obtain biopsy. However, laser marking using cross-sectional image guidance has been 
reported in tethered capsules[8], and future capsule studies could adapt the laser 
marking paradigm to guide biopsy using both en face and cross-sectional features. 
Alternatively, capsule imaging could be performed during EGD, and NBI could be used 
to identify IMPs with associated sub-surface OCT features for biopsy correlation. 
Another limitation was the small patient enrollment, which necessitated the use of an 
unblinded OCT expert to interpret the data while cognizant of patient history. However, 
to our knowledge, this study maps the esophageal mucosa over the widest area with 
the highest resolution to date. The wide imaging field and high resolution provide new 
information on candidate features of dysplasia. The findings are therefore important 
for generating hypotheses that can be tested in future prospective studies with larger 
enrollments.  
  
OCT features in patient 
subgroups 
All 
neoplasia 
(n=7) 
Treatment-
naïve 
neoplasia 
(n=3) 
Ablated 
neoplasia 
(n=4)† 
History of 
NDBE 
(n=9) 
NDBE 
(n=7) †† 
Irregular mucosal patterns (all) 
   No. of patients 
   Occurrences 
       >1cm from GEJ 
   Occurrences per cm2 area* 
 
6/7 
17 (2.4/pt) 
3 (0.43/pt) 
0.56 
 
3/3 
11 (3.7/pt) 
2 (0.67/pt) 
0.40 
 
3/4 
6 (1.5/pt) 
1 (0.25/pt) 
0.72 
 
6/9 
10 (1.1/pt) 
7 (0.77/pt) 
0.06 
 
4/7 
8 (1.1/pt) 
5 (0.71/pt) 
0.05 
Irregular mucosal patterns w/ 
atypical gland clusters 
   No. of patients 
   Occurrences 
       >1cm from GEJ 
   Occurrences per cm2 area 
 
 
5/7 
12 (1.7/pt) 
3 (0.43/pt) 
0.36 
 
 
3/3 
9 (3.0/pt) 
2 (0.67/pt) 
0.31 
 
 
2/4 
3 (0.75/pt) 
1 (0.25/pt) 
0.40 
 
 
2/9†† 
2 (0.22/pt) 
2 (0.22/pt) 
0.008 
 
 
0/7 
0 (0/pt) 
0 (0/pt) 
0 
Atypical gland clusters (all) 
   No. of patients 
   Occurrences 
       >1cm from GEJ 
   Occurrences per cm2 area 
 
7/7 
21 (3.0/pt) 
6 (0.86/pt) 
0.60 
 
3/3 
11 (3.7/pt) 
4 (1.3/pt) 
0.40 
 
4/4 
10 (2.5/pt) 
2 (0.5/pt) 
0.81 
 
7/9 
12 (1.3/pt) 
6 (0.67/pt) 
0.30 
 
5/7 
10 (1.4/pt) 
4 (0.57/pt) 
0.38 
*Mean of occurrences/area for each patient, where total area per patient is approximated by BE 
maximal extent  capsule circumference  fraction of BE area in contact. 
†One patient out of 4 had no visible BE on endoscopy and was thus excluded from the mean 
occurrences/area computation. Features observed at the GEJ were counted as occurrences. 
††The two patients with a history of NDBE having irregular mucosal patterns with underlying atypical 
gland clusters had biopsies with low-grade dysplasia and indefinite for dysplasia. This column reflects 
true NDBE status at the time of imaging.  
   
Supplementary Table 1. Occurrence rates of OCT features in BE, irregular mucosal 
patterns, atypical gland clusters, and irregular mucosal patterns with underlying 
atypical gland clusters in patient subgroups.   
  
Supplementary Figure 1. Tethered capsule volumetric OCT from a patient with 
C0.5M2 and treatment-naïve low-grade (basal crypt) dysplasia with biopsy (inset) from 
previous EGD. En face OCT image (A)  at 200 um depth from surface, averaged over 
80 um depth range (200 um to 280 um), showing dilated glands and (D) en face image 
averaged over ~1 mm depth range (full projection) for contrast enhancement of 
mucosal pattern. Scale bar 1 cm. (B, C) Atypical gland clusters. (E, F) Irregular 
mucosal pattern. (G) Regular mucosal pattern. (H) Absence of mucosal pattern, 
interpreted as irregular. (I-L) Cross-sectional images co-registered to en face regions 
of interest. (I) Shows 3 dilated glands with atypical shape, but does not show the 
substantial clustering of >5 glands seen in the en face image. (K) Shows surface signal 
higher than subsurface, but does not show the mucosal pattern irregularity seen in the 
en face image. (L) Shows loose contact at the gastroesophageal junction, which may 
confound differentiation between gastric and BE tissue. All other scale bars 1 mm. 
  
Supplementary Figure 2. Stacked bar charts of OCT feature occurrences per patient 
and per cm2 of BE area. The features are plotted to avoid repeat counting, such that 
the stacked height indicates the total feature count. Neoplasia patients had a high 
occurrence rate of irregular mucosal patterns with underlying atypical gland clusters, 
while patients with history of NDBE showed a much lower occurrence rate. Atypical 
gland clusters were numerous in all subgroups and associated with a proximity to the 
GEJ (Supplementary Table 1). 
 
Supplementary Video 1: Demonstration of orthoplane viewing of en face and cross-
sectional OCT image series, using dataset presented in Figure 2.  Ultrahigh-speed 
tethered capsules acquire 1,000,000 A-scans per second with 300 images/second at 
a pullback speed of ~1 cm/second. Ultrahigh speed is important for en face OCT 
because each pixel in the en face view requires one A-scan. Orthoplane viewing is 
similar to CT reading and enables rapid and comprehensive assessment of features.  
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